Pages that link to "Q30544314"

The following pages link to DSM-5 criteria for substance use disorders: recommendations and rationale (Q30544314):

Displaying 50 items.

• Mindfulness-based interventions for substance use disorders (Q24187661) (← links)
• Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review (Q26746192) (← links)
• Neural substrates of cue reactivity: association with treatment outcomes and relapse (Q26782278) (← links)
• Cannabinoid abuse and addiction: Clinical and preclinical findings (Q26851944) (← links)
• Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder (Q27015917) (← links)
• Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? (Q28078759) (← links)
• Mischievous responding in Internet Gaming Disorder research (Q28595551) (← links)
• Diagnostic challenges in alcohol use disorder and alcoholic liver disease (Q30435189) (← links)
• Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder (Q30580766) (← links)
• Item banks for substance use from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)): Severity of use and positive appeal of use. (Q30672255) (← links)
• Key Data Gaps Regarding the Public Health Issues Associated with Opioid Analgesics (Q30760780) (← links)
• Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trial (Q30851487) (← links)
• Performance of the RAPS4/RAPS4-QF for DSM-5 compared to DSM-IV alcohol use disorders in the general population: Data from the 2000-2010 National Alcohol Surveys (Q30919504) (← links)
• Risky Drinking, Alcohol Use Disorders, and Health Services Utilization in the U.S. General Population: Data from the 2005 and 2010 National Alcohol Surveys (Q30982471) (← links)
• Cannabis use and anxiety: is stress the missing piece of the puzzle? (Q33359689) (← links)
• Gambling disorder, DSM-5 criteria and symptom severity. (Q33574088) (← links)
• Similarities and Differences between Individuals Seeking Treatment for Gambling Problems vs. Alcohol and Substance Use Problems in Relation to the Progressive Model of Self-stigma. (Q33780714) (← links)
• Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients (Q33806385) (← links)
• Alcohol use disorder, contexts of alcohol use, and the risk of HIV transmission among South African male patrons of shebeens (Q33836115) (← links)
• The Genetics, Neurogenetics and Pharmacogenetics of Addiction (Q33898930) (← links)
• Commentary on Tuithof et al. (2013): Implications of the DSM-5 revision for the analysis of persistence/remission of alcohol use disorder (Q33903774) (← links)
• Comparison of DSM-IV and DSM-5 criteria for alcohol use disorders in VA primary care patients with frequent heavy drinking enrolled in a trial. (Q33912934) (← links)
• Parental psychopathology moderates the influence of parental divorce on lifetime alcohol use disorders among Israeli adults (Q33924505) (← links)
• Childhood maltreatment, stressful life events, and alcohol craving in adult drinkers (Q33934977) (← links)
• A test of the DSM-5 severity scale for alcohol use disorder (Q33972637) (← links)
• Alcohol challenge responses predict future alcohol use disorder symptoms: a 6-year prospective study (Q34375391) (← links)
• The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination (Q34429615) (← links)
• A Prospective 5-Year Re-examination of Alcohol Response in Heavy Drinkers Progressing in Alcohol Use Disorder (Q34482577) (← links)
• Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders (Q34509861) (← links)
• Chronic alcohol self-administration in monkeys shows long-term quantity/frequency categorical stability (Q34574173) (← links)
• Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients (Q34995720) (← links)
• The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample (Q35088286) (← links)
• Border effects on DSM-5 alcohol use disorders on both sides of the U.S.-Mexico border (Q35088372) (← links)
• Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity (Q35143914) (← links)
• Effects of caffeine and its metabolite paraxanthine on intracranial self-stimulation in male rats (Q35316794) (← links)
• Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. (Q35632872) (← links)
• Truth or consequences in the diagnosis of substance use disorders. (Q35635362) (← links)
• PTSD, Depression, Daily Stressors, and Treatment Pathways Among Urban Veterans (Q35674326) (← links)
• Inter-observer reliability of DSM-5 substance use disorders (Q35875576) (← links)
• The effect of cross-border mobility on alcohol and drug use among Mexican-American residents living at the U.S.-Mexico border (Q35889964) (← links)
• Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates (Q35994226) (← links)
• Latent Class Analysis of DSM-5 Alcohol Use Disorder Criteria Among Heavy-Drinking College Students (Q36030895) (← links)
• Epidemiological Studies of Substance Dependence and Abuse in Adults (Q36092343) (← links)
• Coping-motivated marijuana use correlates with DSM-5 cannabis use disorder and psychological distress among emerging adults (Q36101364) (← links)
• The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings (Q36200016) (← links)
• Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III. (Q36248819) (← links)
• Validation of the MINI (DSM IV) Tool for the Assessment of Alcohol Dependence among Young People in Northern Tanzania Using the Alcohol Biomarker Phosphatidylethanol (PEth) (Q36324039) (← links)
• Disorders Related to Use of Psychoactive Substances in DSM-5: Changes and Challenges. (Q36364480) (← links)
• Psychometric modeling of abuse and dependence symptoms across six illicit substances indicates novel dimensions of misuse (Q36372612) (← links)
• Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications (Q36437440) (← links)